AI devices with FDA product code OBH — Monitor, Extracellular Fluid, Lymphedema, Extremity
Product code OBH (“Monitor, Extracellular Fluid, Lymphedema, Extremity” in openFDA) covers 2 devices on the FDA AI-enabled list, from 1 company. Most are reviewed by the Cardiovascular panel (2). The most recent decision was SOZO on April 16, 2018.
2AI devices
1Companies
2017First decision
2018-04-16Latest decision
Trend: devices per year
20172018